Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-01-29

Clinical Trial Update: Pharmacodynamic Differences Between Branded and Unbranded Remifentanil Molecules [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial comparing pharmacodynamic differences between branded and unbranded remifentanil, completed to evaluate potential differences in analge…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Remifentanil (brand) (remifentanil)
  • Remifentanil (generic) (remifentanil)

Snippet

Sponsor: Fundación Universitaria de Ciencias de la Salud | Conditions: Pain | Phase 4 | Status: COMPLETED